GSK swine flu drug approved in US: company
British drug maker GlaxoSmithKline has announced that US regulators have approved its swine flu vaccine for adults in the United States.
"The US Food and Drug Administration (FDA) has approved a... license application for its unadjuvanted influenza A (H1N1) pandemic vaccine," GSK said in a statement received on Wednesday.
"The United States Department of Health and Human Services has placed an order to fill 7.6 million doses of unadjuvanted H1N1 pandemic vaccine from GSK, which will contribute to the approximately 250 million doses secured by the US government."
Although the vaccine is used to fight swine flu, its make-up is different to Pandemrix -- GSK's drug recently approved by EU regulators to treat swine flu in Europe.
(c) 2009 AFP
Citation:
GSK swine flu drug approved in US: company (2009, November 11)
retrieved 19 April 2024
from https://medicalxpress.com/news/2009-11-gsk-swine-flu-drug-company.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no
part may be reproduced without the written permission. The content is provided for information purposes only.
